TI
FLGT icon

Trexquant Investment’s Fulgent Genetics FLGT Stock Holding History

Trexquant Investment’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-140,735
Closed -$3.7M – 1847
2025
Q4 		$3.7M Sell
140,735
-31,637
-18% -$821K 0.03% 737
2025
Q3 		$3.9M Buy
172,372
+50,814
+42% +$1.05M 0.04% 644
2025
Q2 		$2.42M Sell
121,558
-86,849
-42% -$1.69M 0.03% 825
2025
Q1 		$3.52M Buy
208,407
+79,801
+62% +$1.36M 0.04% 647
2024
Q4 		$2.38M Buy
128,606
+41,147
+47% +$803K 0.03% 801
2024
Q3 		$1.9M Sell
87,459
-3,574
-4% -$79.9K 0.02% 832
2024
Q2 		$1.79M Buy
91,033
+56,253
+162% +$1.17M 0.03% 798
2024
Q1 		$755K Buy
+34,780
New +$864K 0.02% 1023
2022
Q2 		– Sell
-11,105
Closed -$693K – 1615
2022
Q1 		$693K Buy
11,105
+8,645
+351% +$569K 0.03% 623
2021
Q4 		$247K Buy
+2,460
New +$216K 0.02% 1024
2021
Q2 		– Sell
-18,646
Closed -$1.8M – 1221
2021
Q1 		$1.8M Buy
+18,646
New +$1.92M 0.17% 164

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Trexquant Investment's FLGT Position: Q1 2026 in Review

Trexquant Investment sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 140,735 shares — an estimated $3.7M sold.

Trexquant Investment first reported a position in FLGT in Q1 2021 and held it in 11 quarters. The position peaked at $3.9M in Q3 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Trexquant Investment reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 140,735 Fulgent Genetics shares in Q1 2026, an estimated $3.7M.
  • Trexquant Investment first reported a position in Fulgent Genetics in Q1 2021 and held it in 11 quarters.
  • Trexquant Investment's Fulgent Genetics position peaked at $3.9M in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.